Globus Medical price target raised to $87 from $78 at BTIG
BTIG raised the firm’s price target on Globus Medical (GMED) to $87 from $78 and keeps a Buy rating on the shares after its Q3 earnings ...
BTIG Sticks to Their Buy Rating for Masimo (MASI)
In a report released today, Marie Thibault from BTIG maintained a Buy rating on Masimo (MASI – Research Report), with a price target of ...
Fintel on MSN8h
BTIG Downgrades Tactile Systems Technology (TCMD)
Fintel reports that on November 5, 2024, BTIG downgraded their outlook for Tactile Systems Technology (NasdaqGM:TCMD) from Buy to Neutral. Analyst Price Forecast Suggests 59.79% Upside As of October ...